Stereotaxis (STXS) Retained Earnings (2010 - 2026)
Stereotaxis' (STXS) quarterly Retained Earnings came in at $603.7 million in Q1 2026, up 5.81% year-over-year from $570.5 million in Q1 2025, and up 1.13% quarter-over-quarter from $597.0 million in Q4 2025.
Analysis
Stereotaxis (STXS) Retained Earnings (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Retained Earnings for 17 consecutive years, with $603.7 million the latest figure, recorded in Q1 2026.
- On a quarterly basis, Retained Earnings rose 5.81% year-over-year to $603.7 million in Q1 2026; TTM through Mar 2026 was $603.7 million, a 5.81% increase from a year earlier, with the FY2025 full-year figure at $597.0 million, up 5.11% from the prior year.
- Retained Earnings was $603.7 million for Q1 2026 at Stereotaxis, up from $597.0 million in the prior quarter.
- Over five years, Retained Earnings peaked at $603.7 million in Q1 2026 and troughed at $535.2 million in Q1 2022.
- A 5-year average of $560.9 million and a median of $556.9 million in 2024 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings gained 1.95% in 2024 and advanced 5.81% in 2026, its largest moves.
- Over 5 years, Retained Earnings stood at $543.4 million in 2022, then grew by 1.97% to $554.1 million in 2023, then climbed by 2.49% to $567.9 million in 2024, then rose by 5.11% to $597.0 million in 2025, then grew by 1.13% to $603.7 million in 2026.
- The last three Retained Earnings figures came in at $603.7 million (Q1 2026), $597.0 million (Q4 2025), and $584.2 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 49.79 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 6.84 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 33.19 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 21.82 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 7.82 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 14.86 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 21.58 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 2.88 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 3.15 Bn |
| 10 | Stereotaxis | 129.55 Mn | 114.93 Mn | 3.79 Mn | 603.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 603.70 Mn |
| Dec 31, 2025 | 596.96 Mn |
| Sep 30, 2025 | 584.22 Mn |
| Jun 30, 2025 | 572.95 Mn |
| Mar 31, 2025 | 570.55 Mn |
| Dec 31, 2024 | 567.93 Mn |
| Sep 30, 2024 | 565.15 Mn |
| Jun 30, 2024 | 559.50 Mn |
| Mar 31, 2024 | 556.88 Mn |
| Dec 31, 2023 | 554.15 Mn |
| Sep 30, 2023 | 551.48 Mn |
| Jun 30, 2023 | 548.78 Mn |
| Mar 31, 2023 | 546.15 Mn |
| Dec 31, 2022 | 543.44 Mn |
| Sep 30, 2022 | 540.71 Mn |
| Jun 30, 2022 | 537.96 Mn |
| Mar 31, 2022 | 535.21 Mn |
| Dec 31, 2021 | 532.64 Mn |
| Sep 30, 2021 | 530.02 Mn |
| Jun 30, 2021 | 527.29 Mn |